pubmed📅 Source: August 27, 2026

Ayush-64 and its potential in post-COVID-19 recovery: a look at the complications of the Delta variant

Share:

Doshas

vatapittakapha

Summary

Researchers investigated the potential of Ayush-64, an Ayurvedic formulation, in mitigating post-COVID-19 complications caused by the Delta variant of SARS-CoV-2. The study, published in the journal Phytomedicine, highlights that Ayush-64 may act on modulating the immune system and reducing inflammation, critical factors in the sequelae of the infection. The authors, including Saini et al., suggest that the combination of herbs present in the formulation may help restore the body's balance, promoting recovery in patients facing persistent symptoms. Although the results are promising, it is important to consider that the study has limitations, such as the need for more clinical investigations to validate these findings and better understand the mechanisms involved.

Key points

  • Ayush-64 may modulate the immune system, aiding in the recovery from post-COVID-19 complications.
  • The formulation contains herbs that act on reducing inflammation, a critical factor in the sequelae of the infection.
  • The study suggests the need for more clinical research to validate the effects of Ayush-64 in humans.

✦ For you

If you are recovering from COVID-19 and facing persistent symptoms, consider observing how your body reacts to changes in diet and routine. Include anti-inflammatory foods and maintain good hydration. Practicing breathing techniques may help improve lung function. If symptoms persist, consult a qualified healthcare professional.

For practitionersExpand

Consider including Ayush-64 in recovery protocols for patients facing post-COVID-19 complications. Assess the patient's condition regarding the immune system and inflammation, adjusting the formulation as necessary. This study provides a basis for discussing the use of complementary therapies in the recovery from viral infections.

Reference

V, Saini et al. Exploring the potential of Ayush-64 in mitigation of post-coronavirus disease of 2019 complications of Delta variant of severe acute respiratory syndrome coronavirus 2. PubMed (NLM E-utilities), 27 ago. 2026. Disponível em: https://pubmed.ncbi.nlm.nih.gov/42721823/. Acesso em: 28 out. 2026.

Curated by Lucas Campos · Ayurvedese®

Share:

← Back to feed

This content is informational and educational. It does not replace individual medical or therapeutic advice. See the terms of use.

Ayush-64 and its potential in post-COVID-19 recovery: a look at the complications of the Delta variant · Ayurvedese® Feed